Haemonetics Corporation
A$93.24
AUD
Last updated on --.
24h volume1.05M
24h highest94.1067 AUD
24h lowest89.9775 AUD
24h Price movement+2.06%
HAE recent prices
24 Hours
+2.06%+A$1.883
30 days
+9.35%+A$7.888
60 days
+21.19%+A$15.97
90 days
+6.26%+A$5.433
Key data
Previous close91.3586 AUD
Market cap3.78B AUD
Volume1.05M
P/E ratio15.430000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)5.3847 AUD
Net income (FY)244.73M AUD
Revenue (FY)1.84B AUD
Last report date5 Feb 2026
About Haemonetics Corporation
HeadquartersBOSTON
Employees (FY)3.02K
Revenue per employee (FY)608.33K AUD
Net income per employee (FY)80.96K AUD
Listed onNew York Stock Exchange
HAE conversion tables
 |  |
|---|---|
| 0.5 HAE | 46.62 AUD |
| 1 HAE | 93.24 AUD |
| 5 HAE | 466.2 AUD |
| 10 HAE | 932.41 AUD |
| |
|---|---|
| 0.5 AUD | 0.0053624 HAE |
| 1 AUD | 0.010725 HAE |
| 5 AUD | 0.053624 HAE |
| 10 AUD | 0.10725 HAE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
HAE is trading at A$93.24, +2.06% over the last 24 hours. Track live moves on the price chart at the top of this page.
The HAE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. HAE is currently trading at A$93.24, +2.06% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on HAE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. HAE's P/E ratio is currently 15.430000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from HAE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against HAE's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Haemonetics Corporation's market cap is currently 3.78B AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume1.05M
24h highest94.1067 AUD
24h lowest89.9775 AUD
24h Price movement+2.06%
Start trade with HAE Perpetual
Sign up to trade